Major test of 1st potential Lyme disease vaccine in 20 years begins in U.S., Europe
Pfizer and French biotech company Valneva are seeking volunteers to test their new vaccine against Lyme disease, which could protect both adults and kids as young as five from the tick-borne illness.
Aucun commentaire:
Enregistrer un commentaire